These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12684124

  • 1. Immune inhibitory effects of renal cell carcinoma extract on lectin and alloantigen-induced peripheral blood and tumor infiltrating lymphocyte blastogenesis.
    Shabtai M, Ye H, Kono K, Takayam T, Terashima K, Tsukuda K, Frischer Z, Waltzer WC, Malinowski K.
    Urol Oncol; 2003; 21(1):27-32. PubMed ID: 12684124
    [Abstract] [Full Text] [Related]

  • 2. [Inhibition of lectin induced peripheral blood lymphocyte proliferation by colorectal cancer extract: a preliminary report of three cases].
    Shabtai M, Slanetz CA, Ye H, Waltzer WC, Malinowski K.
    Harefuah; 2002 Oct; 141(10):862-4, 932. PubMed ID: 12420586
    [Abstract] [Full Text] [Related]

  • 3. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U, Gierschner D, Welchner T, Wetterauer U.
    Anticancer Res; 2003 Oct; 23(1A):433-7. PubMed ID: 12680244
    [Abstract] [Full Text] [Related]

  • 4. Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.
    Ulchaker J, Panuto J, Rayman P, Novick A, Elson P, Tubbs R, Finke JH, Bukowski RM.
    J Immunother; 1999 Jan; 22(1):71-9. PubMed ID: 9924702
    [Abstract] [Full Text] [Related]

  • 5. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
    Kowalczyk D, Skorupski W, Kwias Z, Nowak J.
    Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
    [Abstract] [Full Text] [Related]

  • 6. Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma.
    Sica D, Rayman P, Stanley J, Edinger M, Tubbs RR, Klein E, Bukowski R, Finke JH.
    Int J Cancer; 1993 Apr 01; 53(6):941-7. PubMed ID: 8473051
    [Abstract] [Full Text] [Related]

  • 7. Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes.
    Wu XX, Zeng Y, Jin XH, Kakehi Y.
    Oncol Rep; 2007 Aug 01; 18(2):353-9. PubMed ID: 17611656
    [Abstract] [Full Text] [Related]

  • 8. Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma.
    Wang QJ, Hanada K, Robbins PF, Li YF, Yang JC.
    Cancer Res; 2012 Dec 01; 72(23):6119-29. PubMed ID: 23071066
    [Abstract] [Full Text] [Related]

  • 9. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE, Van Gool SW, Van Poppel H, Baert L, Coorevits L, Van Damme B, Ceuppens JL.
    Clin Exp Immunol; 1997 Sep 01; 109(3):501-9. PubMed ID: 9328129
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the immune reactivity of infiltrating and peripheral lymphocytes from patients with renal cell carcinoma by measuring cytokine secretion.
    Elsässer-Beile U, Wetterauer U, Schultze-Seemann W, Gallati H, Mönting JS, von Kleist S.
    Cancer Immunol Immunother; 1996 Feb 01; 42(2):93-8. PubMed ID: 8620526
    [Abstract] [Full Text] [Related]

  • 11. Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.
    Belldegrun A, Tso CL, Kaboo R, Pang S, Pierce W, deKernion JB, Figlin R.
    J Immunother Emphasis Tumor Immunol; 1996 Mar 01; 19(2):149-61. PubMed ID: 8732698
    [Abstract] [Full Text] [Related]

  • 12. Phenotype analysis of tumour-infiltrating lymphocytes and lymphocytes in peripheral blood in patients with renal carcinoma.
    Kopecký O, Lukesová S, Vroblová V, Vokurková D, Morávek P, Safránek H, Hlávková D, Soucek P.
    Acta Medica (Hradec Kralove); 2007 Mar 01; 50(3):207-12. PubMed ID: 18254275
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes.
    Riccobon A, Gunelli R, Ridolfi R, De Paola F, Flamini E, Fiori M, Saltutti C, Petrini M, Fiammenghi L, Stefanelli M, Granato AM, Cuzzocrea DE, Amadori D.
    Cancer Invest; 2004 Mar 01; 22(6):871-7. PubMed ID: 15641485
    [Abstract] [Full Text] [Related]

  • 14. Use of cryopreserved lymphocytes for assessment of the immunological effects of interferon therapy in renal cell carcinoma patients.
    Sobota V, Bubeník J, Indrová M, Vlk V, Jakoubková J.
    J Immunol Methods; 1997 Apr 11; 203(1):1-10. PubMed ID: 9134025
    [Abstract] [Full Text] [Related]

  • 15. Enhanced susceptibility of c-myc antisense oligonucleotide-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes.
    Mizutani Y, Bonavida B, Fukumoto M, Yoshida O.
    J Immunother Emphasis Tumor Immunol; 1995 Feb 11; 17(2):78-87. PubMed ID: 7647959
    [Abstract] [Full Text] [Related]

  • 16. [Monitoring of anti-tumour cell-mediated response in patients with renal cell carcinoma, disturbance of T cell proliferation].
    Lukesová S, Vroblová V, Hlávková D, Kopecký O, Vokurková D, Morávek P, Safránek H, Soucek P.
    Vnitr Lek; 2008 Feb 11; 54(2):139-45. PubMed ID: 23687704
    [Abstract] [Full Text] [Related]

  • 17. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
    Elsässer-Beile U, Rindsfüser M, Grussenmeyer T, Schultze-Seemann W, Wetterauer U.
    Br J Cancer; 2000 Sep 11; 83(5):637-41. PubMed ID: 10944605
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
    Shabtai M, Ye H, Frischer Z, Martin J, Waltzer WC, Malinowski K.
    J Urol; 2002 Nov 11; 168(5):2216-9. PubMed ID: 12394762
    [Abstract] [Full Text] [Related]

  • 19. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
    Leisegang M, Turqueti-Neves A, Engels B, Blankenstein T, Schendel DJ, Uckert W, Noessner E.
    Clin Cancer Res; 2010 Apr 15; 16(8):2333-43. PubMed ID: 20371691
    [Abstract] [Full Text] [Related]

  • 20. Decrease of intracellular fluorescein fluorescence polarization (IFFP) in human peripheral blood lymphocytes undergoing stimulation with phytohaemagglutinin (PHA), concanavalin A (ConA), pokeweed mitogen (PWM) and anti-CD3 antibody.
    Eisenthal A, Marder O, Dotan D, Baron S, Lifschitz-Mercer B, Chaitchik S, Tirosh R, Weinreb A, Deutsch M.
    Biol Cell; 1996 Apr 15; 86(2-3):145-50. PubMed ID: 8893505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.